Ayer Capital Management as of June 30, 2012
Portfolio Holdings for Ayer Capital Management
Ayer Capital Management holds 31 positions in its portfolio as reported in the June 2012 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Teva Pharmaceutical Industries (TEVA) | 10.4 | $23M | 581k | 39.44 | |
Grifols S A | 6.9 | $15M | 1.6M | 9.60 | |
Alere | 6.2 | $14M | 704k | 19.44 | |
ArthroCare Corporation | 6.1 | $14M | 460k | 29.28 | |
Idenix Pharmaceuticals | 5.7 | $13M | 1.2M | 10.30 | |
Intermune cv 5.0% | 5.5 | $12M | 11M | 1.08 | |
Dynavax Technologies Corporation | 5.1 | $11M | 2.6M | 4.32 | |
Oncothyreon | 4.8 | $11M | 2.3M | 4.68 | |
Ariad Pharmaceuticals | 4.8 | $11M | 609k | 17.21 | |
Celgene Corporation | 4.2 | $9.3M | 145k | 64.16 | |
Cardinal Health (CAH) | 4.1 | $8.9M | 213k | 42.00 | |
McKesson Corporation (MCK) | 4.0 | $8.8M | 94k | 93.76 | |
SciClone Pharmaceuticals | 4.0 | $8.8M | 1.3M | 7.01 | |
CIGNA Corporation | 3.8 | $8.3M | 188k | 44.00 | |
NPS Pharmaceuticals | 3.8 | $8.2M | 955k | 8.61 | |
Dendreon Corp cnv | 3.2 | $7.0M | 6.2M | 1.13 | |
Sanofi-Aventis SA (SNY) | 2.3 | $5.0M | 133k | 37.78 | |
Chemocentryx | 2.3 | $5.0M | 334k | 15.00 | |
Hologic (HOLX) | 1.9 | $4.2M | 231k | 18.04 | |
Threshold Pharmaceuticals | 1.7 | $3.7M | 505k | 7.40 | |
Sucampo Pharmaceuticals | 1.5 | $3.3M | 463k | 7.03 | |
BioSpecifics Technologies | 1.2 | $2.7M | 142k | 18.78 | |
Ligand Pharmaceuticals In (LGND) | 1.2 | $2.6M | 151k | 16.94 | |
Biolinerx Ltd-spons | 1.2 | $2.6M | 1.1M | 2.44 | |
Biomira Inc Cmn Stock cmn | 1.0 | $2.3M | 489k | 4.68 | |
Omeros Corporation (OMER) | 1.0 | $2.3M | 225k | 10.00 | |
Ym Biosciences | 0.7 | $1.5M | 750k | 1.98 | |
WellPoint | 0.6 | $1.2M | 19k | 63.78 | |
Celgene Corp right 12/31/2011 | 0.5 | $1.1M | 602k | 1.88 | |
Cyclacel Pharmaceuticals | 0.3 | $571k | 1.5M | 0.37 | |
Palatin Technologies | 0.0 | $47k | 93k | 0.50 |